Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

114.23 +1.81 (+1.61%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
40 41 Next >
Apple Upstages Goldman Sachs On Monday, Bringing Rally To A Screeching Halt
(Tuesday Market Open) A big slide in the U.S. dollar appears to be pushing stocks higher Tuesday as a slew of earnings arrived before the opening bell. 
Via Benzinga
Preview: Abbott Laboratories's Earnings
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here's what investors need to know before the announcement. Analysts estimate that Abbott... 
Via Benzinga
Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio
Diversified global medical science products maker Abbott (NYSE: ABT) stock is down a modest (-11.5%) on the year. Abbott provides full lifecycle health and medical products from baby formula to... 
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy Product Safety
Abbott's Deep Brain Stimulation Receives FDA's Breakthrough Device Tag To Manage Depression
Via Benzinga
Abbott Reopens Its Michigan Plant Closed Due To Floods: Report
Via Benzinga
Bank Of America And Goldman Sachs Split On Earnings Reports, Possibly Putting Bank Rally In Jeopardy
(Monday Market Open) Investors around the globe appear to be starting the new trading week with a positive attitude as Asian and European markets traded higher overnight helping to boost U.S. equity... 
Via Benzinga
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
7 Analysts Have This to Say About Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Another Way To Understand Market Momentum
(Friday Market Open) U.S. equity futures moved higher early Friday as investors digested better-than-expected June retail sales data and China’s worst GDP numbers since the start of the pandemic. Later... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Hot Inflation And Earnings Misses Weigh On Equity Futures
(Thursday Market Open) The equity markets may take another hit today as JPMorgan Chase (NYSE: JPM) and Morgan Stanley (NYSE: MS) kicked off a new earnings season with a couple of misses as eq 
Via Benzinga
The Fed's Pickle: Whether to Raise Rates to Fight Inflation While Increasing Recession Chances
(Wednesday Market Open) The June Consumer Price Index (CPI) came in much hotter than expected, and equity index futures tumbled before the open.  
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.41% since its last report. The company recently reported that it has 12.98 million shares sold short, which is... 
Via Benzinga
5 Dividend Kings That Income Investors Can Count On
Dividend Kings are usually looked at as a safer bet than other investments because it gives you stable income during market volatility. 
Via InvestorPlace
Abbott Gets FDA Breakthrough Device Status For Depression Therapy System
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to investigate the use of Abbott’s (NYSE: ABT) deep brain stimulation (DBS) system in treatment-resistant... 
Via Benzinga
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.16% on an annualized basis producing an average annual return of 13.1%. Currently, Abbott Laboratories has a... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Will This Dry Eye Rapid Test Prove To Be A Rapid Success?
During the last few years of the COVID-19 pandemic, the term “rapid test” conjures images of overlong cotton swabs reaching heretofore untouched corners of nasal cavities. In reality, rapid tests aid... 
Via Benzinga
Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills
Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes. 
Via Benzinga
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn't slowing down. 
Via InvestorPlace
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription... 
Via Benzinga
Amazon.com To $180? Here's The Biggest Price Target Changes For Friday
Piper Sandler cut Accenture plc (NYSE: ACN) price target from $368 to $305. Accenture shares gained 4.2% to trade at $297.69 on Friday. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market... 
Via Benzinga
ABBOTT LABORATORIES INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23
CNBC Pilot Shortage Pushes American Airlines To Quit Services In 4 Cities 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.